By
Biocon subsidiary Syngene International looking to raise over $50M

Syngene International, a subsidiary of Biocon Ltd, a generics major that also owns the country's largest drug research and development services unit, is looking to raise over $50 million, at least two...

TO READ THE FULL STORY


Leave Your Comment(s)